Biogen Announces First Patient Treated in RESPOND Study Evaluating Benefit of SPINRAZA® (nusinersen) in Patients Treated With Zolgensma® (onasemnogene abeparvovec)

Paul Theisen
Patient Acquisition

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach

Stacey Gandler
Brand Nourishment

Daniel Sontupe
Market Access

Matthew Durham
Omnidynamic Marketing

Joey Cohen
Medication Adherence

David Linetsky
Point-of-Care Marketing

Pat Purcell
Meeting Engagement

Liz Kane
Impactful Strategy

Brenda Snow
Authentic Patient Voice

Frank Burrell
Scientific Storytelling

Suma Ramadas, PhD
Medical Affairs